Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Gene Modified Autologous Neuroblastoma Vaccine for the Post-Chemotherapy Treatment of High-Risk Neuroblastoma

NCT00048386 is registered in ClinicalTrials.gov with Malcolm Brenner as lead sponsor.

NCT NCT00048386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Gene Modified Autologous Neuroblastoma Vaccine for the Post-Chemotherapy Treatment of High-Risk Neuroblastoma
Lead sponsor
Malcolm Brenner
Phase
Phase 1
Overall status
Completed
Start date
November 30, 1999
Completion date
October 31, 2009
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma